NIH-funded research NIH-funded research

Better identifying late health problems in adult survivors of childhood cancer

Official title: Mach-LETSGO: Machine-LEarning of Treatment, Survey, and Genetics towards Obtaining Correct Classification of Chronic Conditions in Adult Survivors in the Childhood Cancer Survivor Study - CCSS Suppl

Funded at St. Jude Children's Research Hospital · NIH-11471611 · Data updated 2026-11-12

This project uses computer learning with clinic exams, medical records, genetics, and survey answers to more accurately find conditions like diabetes, high blood pressure, and heart problems in adults who survived childhood cancer.

More Childhood Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startJuly 20, 1993
Project endNovember 30, 2026
Funding year2026
Award (this year)$325,043
NIH project number3U24CA055727-32S1
Project IDNIH-11471611 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adult survivors of childhood cancer who are enrolled in CCSS or who have completed clinic-based assessments like SJLIFE and have available medical records and genetic data.

Less likely to help

People without a history of childhood cancer or those who cannot provide medical records or genetic information are unlikely to benefit directly from this project.

What this research studies

This team combines detailed clinic assessments from the St. Jude Lifetime Cohort with CCSS survey data, treatment records, and whole-genome information to teach computer models to spot chronic conditions in adult childhood cancer survivors. They will train models on about 2,000 survivors who have both clinic exams and CCSS responses and then test the models on another 436 survivors to check accuracy. Models will use treatment exposures, genetic risk scores, demographic factors, and patterns among survey answers while using techniques to avoid overfitting and to explain predictions. The goal is to correct misreported conditions like diabetes, hypertension, and cardiomyopathy across the larger CCSS group of over 25,000 participants.

Why it matters

Potential benefit: If successful, this work could give survivors and their doctors more accurate information about late health conditions, helping guide better follow-up and care.

How similar studies have gone: Machine-learning methods have improved disease classification in other medical datasets, and applying them to linked SJLIFE and CCSS data is a promising but relatively new approach for survivor late-effect classification.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Armstrong, Gregory — St. Jude Children's Research Hospital
  • Study coordinator: Armstrong, Gregory

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.